NIH-funded research R01 grant

Hippocampal neurogenesis and its link to memory in Alzheimer’s disease

Official title: Hippocampal neurogenesis in cognitive function and dysfunction in Alzheimer's disease.

Funded at University of Illinois at Chicago · NIH-11325347 · Data updated 2026-11-12

This study investigates whether new brain cells form in the hippocampus of people with Alzheimer’s and how this may relate to memory and cognitive decline.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Illinois at Chicago
NIH-funded
Lab location1 site (Chicago, UNITED STATES)
Project startMay 15, 2022
Project endApril 30, 2027
Funding year2026
Award (this year)$673,320
NIH project number5R01AG076940-05
Project IDNIH-11325347 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 21 and older with Alzheimer’s disease dementia or related dementias, and controls without cognitive impairment for comparison.

Less likely to help

Patients without Alzheimer’s or related dementia may not directly benefit from this study.

What this research studies

Researchers at the University of Illinois at Chicago will study human brain tissue from individuals with and without Alzheimer’s disease to understand if new hippocampal neurons appear and how they correlate with memory. The project builds on prior findings that neurogenesis may persist into old age but differs in Alzheimer’s. By examining brain samples and related data, the team aims to clarify whether promoting neurogenesis could support cognitive function in AD/ADRD. The findings could inform future approaches to protect memory and potentially guide therapeutic strategies.

Why it matters

Potential benefit: Better understanding of hippocampal neurogenesis could lead to new ideas for protecting or improving memory in people with Alzheimer’s disease.

How similar studies have gone: Previous human studies have shown variable evidence of hippocampal neurogenesis, making this study important for clarifying its role in AD/ADRD.

Where this research is happening

  • University of Illinois at Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Lazarov, Orly — University of Illinois at Chicago
  • Study coordinator: Lazarov, Orly

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.